Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Efficacy of Recombinant Human Nerve Growth Factor (rhNGF) Treatment in Patients With Neuropathic Corneal Pain (NCP)

NCT05700864 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT05700864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05700864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Efficacy of Recombinant Human Nerve Growth Factor (rhNGF) Treatment in Patients With Neuropathic Corneal Pain (NCP)
Lead sponsor
Tufts Medical Center
Phase
Phase 1
Overall status
Withdrawn
Start date
November 1, 2022
Completion date
December 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal disease, neuropathy